tm logo
GEGANT
Live/Registered
REGISTERED

on 28 Apr 2020

Last Applicant/ Owned by

Serial Number

79265476 filed on 05th Jun 2019

Registration Number

6039395 registered on 28th Apr 2020

in the Principal Register

Correspondent Address

Kari Moyer-Henry

Kari Moyer-Henry

15030 Avenue of Science

Suite 201

San Diego, CA 92128

Filing Basis

No Filing Basis

Disclaimer

NO DATA

GEGANT

Pharmaceutical advice in relation to radiopharmaceutical products, namely, 68-Ga products for use in medicine for third parties, namely, advice in relation to radiopharmaceuticals for the therapy and diagnosis of diseases, in particular tumour diseases, namely, pharmaceutical advice in relation to radiopharmaceuticals coupled to somatostatin analogues and advice in relation to the manufacture of p Read More

Classification Information


Class [005]
Pharmaceutical Products


Radiopharmaceutical preparations for use in oncology, namely, radiopharmaceuticals containing Gallium-68 for treating and diagnosing tumours; anti-cancer preparations, namely, Gallium-68 compounds, including 68-Ga chlorides; anti-cancer preparations, namely, Gallium-68 for use in the field of targeted radionuclide therapy of cancers, in particular prostate cancer and neuroendocrine tumours; cancer diagnostic preparations for medical purposes, namely, Gallium-68 compounds, including 68-Ga peptide chelates, in particular 68-Ga-Dotatoc and 68-Ga-Dotatate, 68-Ga salts, in particular 68-Ga chlorides; Gallium-68 for use as radiotracers in pet scans or combined PET/CT scans

Class [010]
Medical Instrument Products


Medical apparatus and instruments for use in positron emission tomography (PET) imaging, namely, Ge-68/Ga-68 radionuclide generators for pharmaceutical purposes as source of radionuclides being positron emitters in the field of Positron Emission Tomography - Computed Tomography (PET/CT)

Class [042]
Computer & Software Services & Scientific Services


Scientific and technological services and research on radiopharmaceutical products, namely, 68-Ga products for use in medicine for third parties, namely, services relating to radiopharmaceuticals for the therapy and diagnosis of diseases and services relating to radiopharmaceuticals coupled to somatostatin analogues for the diagnosis and treatment of tumours, namely, scientific and product research and development

Class [044]
Medical, Beauty & Agricultural Services


Pharmaceutical advice in relation to radiopharmaceutical products, namely, 68-Ga products for use in medicine for third parties, namely, advice in relation to radiopharmaceuticals for the therapy and diagnosis of diseases, in particular tumour diseases, namely, pharmaceutical advice in relation to radiopharmaceuticals coupled to somatostatin analogues and advice in relation to the manufacture of personalised radiopharmaceutical products containing 68-Ga for use in medicine

Mark Details


Serial Number

No 79265476

Mark Type

No Service Mark

Attorney Docket Number

No 540.318US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
26th Sep 2020FINAL DECISION TRANSACTION PROCESSED BY IB
08th Sep 2020FINAL DISPOSITION NOTICE SENT TO IB
04th Sep 2020FINAL DISPOSITION PROCESSED
28th Jul 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03rd Jul 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
28th Apr 2020REGISTERED-PRINCIPAL REGISTER
14th Feb 2020NOTIFICATION PROCESSED BY IB
11th Feb 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11th Feb 2020PUBLISHED FOR OPPOSITION
29th Jan 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB